Patents
Patents for C07C 59 - Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups oh, o-metal, cho, keto, ether, groups, groups, or groups (14,643)
10/2003
10/09/2003CA2477764A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/08/2003CN1446790A Medicinal grade ferrum citricum iron-59 citrate and its preparation method
10/07/2003US6630603 reduced-pressure distillation of a concentrated lactic acid solution having a total acid content of at least 95 wt % and a content of monomeric lactic acid of at least 80 wt %, based on the concentrated lactic acid solution, crystallization
10/07/2003US6630510 Substituted succinic acid metallo-β-lactamase inhibitors and their use in treating bacterial infections
10/07/2003US6630177 Products extracted from a plant of the genus Commiphora, particularly the Commiphora mukul plant, extracts containing same and applications thereof, for example in cosmetics
10/02/2003US20030187287 Synthesis intermediate products for producing vitamin d derivatives
10/02/2003US20030187280 (Per) haloethers
10/02/2003US20030187071 Process and intermediates to prepare latanoprost
10/02/2003US20030186947 Such as 4-((5-cyclopropyl-methyl-amino)-8,8-dimethyl-5,6,7,8-tetrahydro-naphthalene -2yl-ethynyl)-benzoic acid for treating diseases responsive to treatment by retinoids
10/02/2003US20030186823 Environmentally compatible, easily biodegradable lubricants, lubricant components, lubricant additives, hydraulic oils, pressure transfer media, transmission oils and functional liquids
10/02/2003US20030186399 Comprises aerobic cultivation of Dipldia gossypina, followed by isolation or esterification; for use in cigarettes, hair sprays
10/01/2003EP1347955A1 New mandelic acid derivatives and their use as throbin inhibitors
10/01/2003EP1347950A1 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of gamma-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses
09/2003
09/30/2003US6627763 Compounds having protected hydroxy groups
09/30/2003US6627656 Method of treatment using phenyl and biaryl derivatives as prostaglandin E inhibitors and compounds useful therefore
09/30/2003CA2254750C Inhibition of matrix metalloproteases by 2-(.omega.-aroylalkyl)-4-biaryl-oxobutyric acids
09/30/2003CA2103167C Compositions and methods for inhibiting browning in foods and beverages
09/25/2003WO2003078379A1 AMORPHOUS Hmg-CoA REDUCTASE INHIBITORS OF DESIRED PARTICLE SIZE
09/25/2003WO2002030882A3 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
09/25/2003US20030181490 For therapy and prophylaxis of acquired immune deficiency syndrome (AIDS), or ARC
09/24/2003EP1345884A1 Anti-viral compounds
09/24/2003CN1443756A Bicyclic aromatic compound
09/23/2003US6624188 Method of treatment with compounds having retinoid-like activity and reduced skin toxicity and lacking teratogenic effects
09/23/2003CA2098122C Anti-atherosclerotic aryl compounds
09/23/2003CA2084041C Diphenyl acetic acid derivatives
09/18/2003WO2003028600B1 Wipe formulation
09/18/2003US20030176736 Lactic acid processing; methods; arrangements; and, products
09/18/2003US20030176721 Method for the production of trifluoroethoxy-substituted benzoic acids
09/18/2003US20030176509 Methods and products related to 16-HETE analogs
09/18/2003US20030176506 For therapy of leukemia or other forms of cancer or for treating disease conditions caused by apoptosis of cells
09/18/2003US20030176495 HIV Integrase inhibitors
09/17/2003EP0769940B1 INDENE sPLA2 INHIBITORS
09/17/2003CN1121385C Haphthyl compounds, intermediates, compositions and methods of use
09/17/2003CN1121376C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives and matrix metalloprotease inhibitors
09/17/2003CN1121375C Oligosaccharide synthesis
09/17/2003CN1121374C Novel trienoic retinoid compounds and method
09/16/2003US6620919 Lipoxin compounds and their use in treating cell proliferative disorders
09/12/2003WO2003074575A1 Polymerizable compound, polymer compound, composition using such compound, and image forming method and apparatus
09/12/2003WO2003074469A1 Novel cinnamate salts, method for production and use thereof as medicaments
09/11/2003US20030171616 Process for producing acyl fluoride and carboxylic acid salt
09/11/2003US20030171435 New amphetamine derivatives, antibodies against them and pharmaceutical compositions containing them
09/10/2003EP1341543A2 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
09/10/2003CN1441775A Hiv整合酶抑制剂 Hiv integrase inhibitors
09/04/2003US20030166968 Controlling temperature during crystallization
09/04/2003US20030166727 Antiinflammatory agents having analgesic, antianxiety, anticonvulsive, neuroprotective, antipsychotic and anticancer activity
09/04/2003US20030166725 Compounds active at the glucocorticoid receptor
09/04/2003US20030166724 For treating or delaying progression or onset of obesity, hypercholesterolemia, atherosclerosis, depression, osteoporosis, hypothyroidism, non-toxic goiter, reduced bone mass, density or growth, eating disorders, cardiac arrhythmia
09/04/2003US20030166487 Normally liquid, omega-hydrofluoroalkyl ether compounds (and selected mixtures thereof) have a saturated perfluoroaliphatic chain of carbon atoms interrupted by one or more ether oxygen atoms. The compounds can be prepared, by decarboxylation of
09/03/2003EP1144718A4 Indium source reagent compositions
09/03/2003CN1440381A Process for preparation of substituted octanoyl amides
09/03/2003CN1440379A Preparation of (R)-2-alkyl-3-phenylpropionic acids
09/03/2003CN1439628A Ferulaic acid esters and preparation and application thereof
09/02/2003US6613914 Process for preparing 1, 5-diaryl-3-substituted pyrazoles
09/02/2003US6613900 Cephalotaxane derivatives and process for their preparation
08/2003
08/28/2003WO2003070717A1 Process for the manufacture of hmg-coa reductase inhibitory mevalonic acid derivatives
08/28/2003WO2003070686A1 Substituted phenylalkanoic acid derivative and use thereof
08/28/2003US20030162996 Method for isolating polymethyl alkanoic acids and disposal of the resulting wastes
08/28/2003US20030162974 Synthesis of oxygen-substituted benzocycloheptenes as valuable intermediate products for the production of tissue-selective estrogens
08/28/2003US20030162823 Novel C-4 substituted retinoids
08/27/2003EP1337533A2 Resolution of trans-7-(hydroxy-methyl)octa-hydro-2h-pyrido-1,2a)pyrazine
08/27/2003CN1119313C Inhibition of matrix metallo proteases by 2-(omega-aroylalkyc)-4-biaryl-oxobutyric acids
08/27/2003CN1119312C Industrial continuous process for preparing o-sodium hydroxy-mandelate
08/26/2003US6610878 Poly(3-cyclopropyl-3-hydroxypropionate) and processes for its preparation and derivatives thereof
08/26/2003US6610877 Treating photo and/or age damaged skin
08/23/2003CA2473075A1 Process for the manufacture of hmg-coa reductase inhibitory mevalonic acid derivatives
08/20/2003EP1336600A2 Dimer-selective RXR modulators and methods for their use
08/20/2003EP1335893A1 Method for producing poly- or monomethylol alkanoic acids
08/20/2003CN1437441A Novel diphenylethylene compound
08/20/2003CN1118450C Novel L-threonic acid derivatives
08/19/2003US6608194 Hypolipidemic, antihyperglycemic, antiobesity and hypocholes-terolemic agents
08/14/2003WO2003066573A1 Metal salts of carnitines, dietary supplements containing same and dietary kits for counteracing sexual disorders in male subjects
08/14/2003WO2003035237A3 Compounds for use as surfactants
08/14/2003US20030153579 Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient
08/14/2003US20030153544 Fatty acid derivatives
08/12/2003US6605741 Catalytic reacting acetylene with epoxide
08/07/2003WO2003064369A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
08/07/2003US20030149303 Simultaneous halogenation and hydroxylation under lactonization, azidation, then amination to form 2(S),4(S),5(S),7(S)-2,7-dialkyl-4-hydroxy-5-amino-8-aryl-octanoyl amides
08/07/2003US20030149107 For therapy of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis
08/07/2003US20030149104 Tri-substituted phenyl derivatives and analogues
08/07/2003US20030149094 Compositions comprising ether compounds and pharmaceutical uses therefor
08/07/2003CA2473162A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
08/06/2003EP1333021A2 Compositions containing derivatives of jasmonic acid and their use for stimulating skin peeling
08/06/2003EP1333020A2 "(PER)Haloethers"
08/06/2003EP1332196A1 Blends of quinone alkide and nitroxyl compounds as polymerization inhibitors
08/06/2003EP1331936A2 Mammalian metabolites of a tachykinin receptor antagonist
08/06/2003EP0874800B1 Indane dimer compounds with smooth muscle relaxing and/or mast cell stabilising and/or antiinflammatory activity
08/06/2003EP0865419B1 Indane dimer compounds and their pharmaceutical use
08/05/2003US6603023 Synthesis of epothilones, intermediates thereto and analogues thereof
08/05/2003US6603019 Phenylacetic or heteroarylacetic acid derivatives, retinoic acid inducible enzyme, used to treat diseases responsive to retinoids
08/05/2003US6602907 Treatment of breast cancer
08/05/2003US6602901 Antidiabetic agents, obesity
08/05/2003US6602549 Indium source reagent composition, and use thereof for deposition of indium-containing films on subtrates and ion implantation of indium-doped shallow junction microelectronic structures
07/2003
07/31/2003WO2003062179A1 Novel process for producing 1,2-diol
07/31/2003WO2003061595A2 Antibodies against and compositions containing new amphetamine derivatives
07/31/2003WO2002030863A3 Ether compounds and compositions for cholesterol management and related uses
07/31/2003WO2002018361A3 Compounds having activity as inhibitors of cytochrome p450rai
07/31/2003US20030144546 Process for producing optically active carboxylic acid subtituted in 2-position
07/31/2003US20030144523 Epothilone derivatives, method for producing same and their pharmaceutical use
07/31/2003CA2474259A1 Antibodies against and compositions containing new amphetamine derivatives
07/30/2003EP1330534A1 Method for obtaining 12-hydroxystearic acid
1 ... 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 ... 147